Alimentiv is a global full-service GI-focused Clinical Research Organization (CRO) with 30+ years of experience offering comprehensive end-to-end clinical trial services and advanced imaging solutions.
We are a trusted partner for leading top pharmaceutical & biotech companies, having supported 80% of current approved GI drugs on the market and conducted 40+ full-service trials in the past five years.
Our extensive network of 5,000+ global sites ensures rapid study activation and maximizes patient enrollment success. Alimentiv’s unmatched expertise in GI and liver-associated diseases spans all trial phases for a variety of complex trials, including adaptive and virtual designs.
Alimentiv combines high-quality medical expertise with innovative imaging technologies, like the industry-leading Notō software, to our custom software solution for central reading scoring workflow across various GI modalities.
We offer cutting-edge precision medicine and translational research services, including a specialty histopathology laboratory, AcelaBio. Our commitment to excellence is reflected in our collaborations with GI experts and key opinion leaders to develop and validate outcome measures, manage multi-center trials, and provide centralized imaging solutions that benefit both patients and sponsors.
